ABRomics present at RICAI 2025

The 45th Interdisciplinary Meeting on Anti-Infective Chemotherapy (RICAI) took place on December 15 and 16, 2025, at the Palais des Congrès in Paris. RICAI is the leading French-language event dedicated to clinical microbiology and infectious diseases, bringing together 2,000 people in Paris each year.

Many topics are covered, including:

– Clinical practice and therapeutics

– Bacteriology

– Virology

– Parasitology and mycology

– Hygiene and infectious risk management

More information about this edition: https://www.ricai.fr

Contribution from the ABRomics consortium:

– A presentation of the platform by Claudine Médigue

December 16 | 10:45 a.m. – 11:00 a.m. | ABRomics: an integrated platform for antibiotic resistance research and surveillance

ABRomics aims to address a major public health issue: antibiotic resistance. Multidrug-resistant bacteria (MDRB) and antibiotic resistance genes carried by mobile genetic elements are spreading between humans, animals, and the environment. ABRomics is a secure, multisectoral, open digital platform designed to analyze genomic and metagenomic data (subsequent versions) related to antibiotic resistance.

The presentation focused on the features of the genomic version of PF ABRomics currently in production, highlighting in particular the standardization of data and analysis workflows, and the benefits of the ABRomics-DB community database. 

– Claudine Médigue was also present during the two days at the IFB/ABRomics booth in the exhibitors’ area to present the ABRomics project and give demonstrations of the analysis platform (analysis.abromics.fr)!